Abrams Benjamin A, Murray Kimberly A, Mahoney Katharine, Raymond Kristen M, McWilliams Shannon K, Nichols Stephanie, Mahmoudi Elham, Mayes Lena M, Fernandez-Bustamante Ana, Mitchell John D, Meguid Robert A, Zanotti Giorgio, Bartels Karsten
Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado.
Center for Outcomes Research and Evaluation, Maine Medical Center Research Institute, Portland, Maine.
Ann Thorac Surg. 2020 Nov;110(5):1714-1721. doi: 10.1016/j.athoracsur.2020.04.048. Epub 2020 Jun 1.
Postoperative analgesia is paramount to recovery after thoracic surgery, and opioids play an invaluable role in this process. However, current 1-size-fits-all prescribing practices produce large quantities of unused opioids, thereby increasing the risk of nonmedical use and overdose. This study hypothesized that patient and perioperative characteristics, including 24-hour before-discharge opioid intake, could inform more appropriate postdischarge prescriptions after thoracic surgery.
This prospective observational cohort study was conducted in 200 adult thoracic surgical patients. The cohort was divided into 3 groups on the basis of 24-hour before-discharge opioid intake in morphine milligram equivalents (MME): (1) no (0 MME), (2) low (>0 to ≤22.5 MME), or (3) high (>22.5 MME) before-discharge opioid intake. Logistic regression was used to analyze the association of patient and perioperative characteristics with self-reported after-discharge opioid use.
Univariate analysis showed that preoperative opioid use, 24-hour before-discharge acetaminophen and gabapentinoid intake, and 24-hour before-discharge opioid intake were associated with higher after-discharge opioid use. Multivariable modeling demonstrated that 24-hour before-discharge opioid intake was most significantly associated with after-discharge opioid use. For example, compared with patients who took high amounts of opioids before discharge, patients who took no opioids before discharge were 99% less likely to take a high amount of opioids after discharge compared with taking none (odds ratio, 0.011; 95% confidence interval, 0.003 to 0.047; P < .001).
Assessment of 24-hour before-discharge opioid intake may inform patient requirements after discharge. Opioid prescriptions after thoracic surgery can thereby be targeted on the basis of anticipated needs.
术后镇痛对于胸外科手术后的恢复至关重要,阿片类药物在此过程中发挥着不可替代的作用。然而,目前一刀切的处方做法导致大量阿片类药物未被使用,从而增加了非医疗使用和过量用药的风险。本研究假设患者和围手术期特征,包括出院前24小时的阿片类药物摄入量,可为胸外科手术后更合适的出院后处方提供依据。
本前瞻性观察性队列研究纳入了200例成年胸外科手术患者。根据出院前24小时以吗啡毫克当量(MME)计算的阿片类药物摄入量,将该队列分为3组:(1)无(0 MME),(2)低(>0至≤22.5 MME),或(3)高(>22.5 MME)出院前阿片类药物摄入量。采用逻辑回归分析患者和围手术期特征与自我报告的出院后阿片类药物使用之间的关联。
单因素分析显示,术前阿片类药物使用、出院前24小时对乙酰氨基酚和加巴喷丁类药物摄入量以及出院前24小时阿片类药物摄入量与出院后较高的阿片类药物使用有关。多变量模型表明,出院前24小时阿片类药物摄入量与出院后阿片类药物使用最显著相关。例如,与出院前服用大量阿片类药物的患者相比,出院前未服用阿片类药物的患者出院后服用大量阿片类药物的可能性比不服用阿片类药物的患者低99%(比值比,0.011;95%置信区间,0.003至0.047;P <.001)。
评估出院前24小时的阿片类药物摄入量可为出院后患者的需求提供依据。胸外科手术后的阿片类药物处方因此可以根据预期需求进行针对性调整。